COVID-19 and vaccination against SARS-CoV-2 in patients with neuromyelitis optica spectrum disorders

BACKGROUND: Reports on outcomes of COVID-19 in patients with neuromyelitis optica spectrum disorder (NMOSD) are scarce, as well as those related to the safety profile of the vaccines in this population. The aim of this survey is to present demographic and clinical characteristics of patients with NM...

Descripción completa

Detalles Bibliográficos
Autores principales: Jovicevic, Vanja, Ivanovic, Jovana, Andabaka, Marko, Tamas, Olivera, Veselinovic, Nikola, Momcilovic, Nikola, Mesaros, Sarlota, Pekmezovic, Tatjana, Drulovic, Jelena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526109/
https://www.ncbi.nlm.nih.gov/pubmed/35158424
http://dx.doi.org/10.1016/j.msard.2021.103320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526109/
https://www.ncbi.nlm.nih.gov/pubmed/35158424
http://dx.doi.org/10.1016/j.msard.2021.103320

Ejemplares similares